These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 35015607)
21. MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer. Kapora E; Feng S; Liu W; Sakhautdinova I; Gao B; Tan W Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31266812 [TBL] [Abstract][Full Text] [Related]
22. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis. Cheng Z; Jiang S; Tao R; Ge H; Qin J Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2. Hou S; Zhang X; Yang J Exp Cell Res; 2022 Jan; 410(1):112929. PubMed ID: 34793775 [TBL] [Abstract][Full Text] [Related]
24. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982 [TBL] [Abstract][Full Text] [Related]
25. Ectodermal‑neural cortex 1 affects the biological function of lung cancer through the MAPK pathway. Wu C; Wang X; Wu X; Chen X Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693958 [TBL] [Abstract][Full Text] [Related]
26. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577. Yang J; Liang B; Hou S J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914 [TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis. Gao Y; Zou T; Liang W; Zhang Z; Qie M Cancer Gene Ther; 2021 Jun; 28(6):619-633. PubMed ID: 33139818 [TBL] [Abstract][Full Text] [Related]
28. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis. Yi B; Li H; Cai H; Lou X; Yu M; Li Z J Cell Mol Med; 2022 Jan; 26(2):475-490. PubMed ID: 34890108 [TBL] [Abstract][Full Text] [Related]
29. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2. Wu EY; Huang LP; Bao JH Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205 [TBL] [Abstract][Full Text] [Related]
30. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression. Liu Y; Guo C; Li F; Wu L Cell Biochem Funct; 2020 Jan; 38(1):58-65. PubMed ID: 31732974 [TBL] [Abstract][Full Text] [Related]
31. LOXL1-AS1 Drives The Progression Of Gastric Cancer Via Regulating miR-142-5p/PIK3CA Axis. Li M; Cai O; Tan S Onco Targets Ther; 2019; 12():11345-11357. PubMed ID: 31908498 [TBL] [Abstract][Full Text] [Related]
32. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2. Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653 [TBL] [Abstract][Full Text] [Related]
33. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related]
34. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis. Shao S; Wang C; Wang S; Zhang H; Zhang Y Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131 [TBL] [Abstract][Full Text] [Related]
35. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis. Zhang L; Xie H; Li S J Bone Miner Metab; 2020 Nov; 38(6):794-805. PubMed ID: 32651705 [TBL] [Abstract][Full Text] [Related]
36. LncRNA FLVCR1-AS1 mediates miR-23a-5p/SLC7A11 axis to promote malignant behavior of cervical cancer cells. Zhou X; Zhao X; Wu Z; Ma Y; Li H Bioengineered; 2022 Apr; 13(4):10454-10466. PubMed ID: 35465835 [TBL] [Abstract][Full Text] [Related]
37. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo. Fu J; Zhang Y; Wang M; Hu J; Fang Y J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661 [TBL] [Abstract][Full Text] [Related]
39. MEF2C-AS1 regulates its nearby gene MEF2C to mediate cervical cancer cell malignant phenotypes in vitro. Guo Q; Zhang L; Zhao L; Pang X; Wang P; Sun H; Liu S Biochem Biophys Res Commun; 2022 Dec; 632():48-54. PubMed ID: 36198203 [TBL] [Abstract][Full Text] [Related]
40. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma. Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]